IN-VIVO ANTI-CD3 TREATMENT OF AUTOIMMUNE PATIENTS
Authors:
- L. ChatenoudLCL. Chatenoud
- C. FerranCFC. Ferran
- J.F. BachJBJ.F. Bach
- 15 July 1989
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 334 (8655) , 164
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Systemic Reaction to the Anti–T-Cell Monoclonal Antibody OKT3 in Relation to Serum Levels of Tumor Necrosis Factor and Interferon-αNew England Journal of Medicine, 1989
- Clinical use of OKT3: The role of cytokine release and xenosensitizationJournal of Autoimmunity, 1988
- The Human Immune Response to the OKT3 Monoclonal Antibody Is OligoclonalScience, 1986
- Unusually restricted anti‐isotype human immune response to OKT3 monoclonal antibodyEuropean Journal of Immunology, 1984